Press release
Lawsuit filed for Investors who lost money with shares of Neogen Corporation (NASDAQ: NEOG)
A lawsuit was filed on behalf of investors in Neogen Corporation (NASDAQ: NEOG) shares over alleged securities laws violations.
Investors who purchased shares of Neogen Corporation (NASDAQ: NEOG) have certain options and for certain investors are short and strict deadlines running. Deadline: September 16, 2025. NASDAQ: NEOG investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Lansing, MI Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally.
Neogen Corporation (NASDAQ: NEOG) reported that itsTotal Revenue declined from $924.22 million for the 12 months period that ended on May 31, 2024 to $894.66 million for the 12 months period that ended on May 31, 2025, and that its Net Loss over those respective time periods increased from $9.42 million to over $1.06 billion.
On January 10, 2025. Neogen Corporation (NASDAQ: NEOG) revealed that GAAP net income in the second quarter was significantly negative due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition and cut its FY25 revenue and EBITDA guidance. Neogen also revealed that, as of November 30, 2024, the Company had material weaknesses in its internal control over financial reporting.
In its next financial quarter, on April 9, 2025, Neogen Corporation (NASDAQ: NEOG) announced that quarterly revenue fell 3.4% to $221 million due to integration issues and again cut its FY25 guidance and noted that capital expenditures were expected to be $100 million as a result of lowered adjusted EBITDA and a pull-forward of integration-related capital expenditures into FY25. Neogen also announced that CEO Adent would be stepping down.
Finally, on June 4, 2025, Neogen Corporation (NASDAQ: NEOG) revealed that it expected "EBITDA margin to probably be around the high-teens" which represented a considerable drop from the previous quarter's profit margin of 22%.
Shares of Neogen Corporation (NASDAQ: NEOG) declined from $23.87 per share on August 16, 2023, to as low as $4.53 per share on June 4, 2025.
The plaintiff claims that between January 5, 2023 through June 3, 2025, the Defendants misrepresented the status of the 3M integration and failed to disclose the negative impact of integration issues on the financial health of Neogen, that the defendants issued a series of materially false and misleading statements which led investors to believe that the integration was progressing smoothly, and that the defendants downplayed integration "inefficiencies" and assured investors that they were fully aware and committed to resolving the issues quickly.
Those who purchased shares of Neogen Corporation (NASDAQ: NEOG) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lawsuit filed for Investors who lost money with shares of Neogen Corporation (NASDAQ: NEOG) here
News-ID: 4144712 • Views: …
More Releases from Shareholders Foundation, Inc.
Investigation announced for Long-Term Investors in shares of Avis Budget Group, …
An investigation was announced on behalf of current long-term investors in shares of Avis Budget Group, Inc. (NASDAQ: CAR) concerning potential breaches of fiduciary duties by certain directors of Avis Budget Group, Inc.
Investors who are current long term investors in Avis Budget Group, Inc. (NASDAQ: CAR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
NYSE: ANRO Lawsuit Alert: Investors who lost money with shares of Alto Neuroscie …
An investor, who purchased shares of Alto Neuroscience, Inc. (NYSE: ANRO), filed a lawsuit over alleged violations of Federal Securities Laws by Alto Neuroscience, Inc. in connection with certain allegedly false and misleading statements made between February 2, 2024 and October 22, 2024 and in connection with the Company's initial public offering conducted on or about February 2, 2024 (the "IPO" or "Offering").
Investors who purchased shares of Alto Neuroscience, Inc.…
Investigation announced for Investors who hold shares of Zenas BioPharma, Inc. ( …
An investigation was announced for long-term investors in shares of Zenas BioPharma, Inc. (NASDAQ: ZBIO) concerning potential breaches of fiduciary duties by certain directors of Zenas BioPharma, Inc.
Investors who are current long term investors in Zenas BioPharma, Inc. (NASDAQ: ZBIO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in NASDAQ: ZBIO stocks…
Lawsuit filed for Investors who lost money with shares of RxSight, Inc. (NASDAQ: …
An investor, who purchased shares of RxSight, Inc. (NASDAQ: RXST), filed a lawsuit over alleged violations of Federal Securities Laws by RxSight, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of RxSight, Inc. (NASDAQ: RXST) have certain options and for certain investors are short and strict deadlines running. Deadline: September 22, 2025. NASDAQ: RXST investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
More Releases for Neogen
Aquaculture Test Kit Market: Know Opportunity Ahead | Aquatic Diagnostics, Neoge …
The latest study released on the Global Aquaculture Test Kit Market by HTF MI Research evaluates market size, trend, and forecast to 2031. The Aquaculture Test Kit market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the…
Bovine Mastitis Market Is Booming So Rapidly | Neogen, Vetoquinol, Dechra
The "Bovine Mastitis Market" intelligence report, just published by USD Analytics, covers a micro-level study of important market niches, product offers, and sales channels. To determine market size, potential, growth trends, and competitive environment, the Bovine Mastitis Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study featured Zoetis,…
Specimen Collection Cards Market Is Booming So Rapidly | Neogen, Whatman, Perkin …
USD Analytics Market published a new research publication on "Global Specimen Collection Cards Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study, you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market-associated stakeholders. The growth of the Specimen Collection Cards market was mainly driven by the increasing R&D spending across the world.
Major players profiled in the…
Veterinary Molecular Diagnostics Market Is Booming Worldwide: Neogen, Virbac, Ra …
The "Veterinary Molecular Diagnostics Market" intelligence report, just published by USD Analytics Market, covers insurers' micro-level study of important market niches, product offers, and sales channels. In order to determine market size, potential, growth trends, and competitive environment, the Veterinary Molecular Diagnostics Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major…
Salmonella Testing Market Is Booming Worldwide with Fujirebio, Leica, Neogen
Advance Market Analytics published a new research publication on “Salmonella Testing Market Insights, to 2027″ with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Salmonella Testing market was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Equine Healthcare Market To See Extraordinary Growth | Neogen, Merck, Evonik Ind …
The Global Equine Healthcare Market outlook survey highlights the dynamics at play in each of the subsegments of Equine Healthcare Industry to better elaborate current state, emerging trends and potential areas of focus. Discerning stakeholders in the Equine Healthcare market will be able to use this study to evaluate opportunities and challenges in the context of an increasingly complex healthcare and life sciences marketplace. To understand big picture lot of…
